SPM 927

DRUG7 trials

Sponsors

UCB Pharma

Conditions

Diabetic NeuropathiesDiabetic NeuropathyEpilepsies, PartialEpilepsyPartial Seizures With or Without Secondary GeneralizationPostherpetic Neuralgia

Phase 2

Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures

CompletedNCT00151879

UCB PharmaEpilepsies, Partial

Start: 2005-02-28End: 2006-05-31Updated: 2014-09-22

A Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy

CompletedNCT00235469

UCB PharmaDiabetic Neuropathy

Start: 2004-04-30End: 2005-06-30Updated: 2014-09-22

An Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Postherpetic Neuralgia (PHN)

CompletedNCT00238511

UCB PharmaPostherpetic Neuralgia

Start: 2002-11-30End: 2005-01-31Updated: 2014-09-22

Phase 3

Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy

CompletedNCT00135109

UCB PharmaDiabetic Neuropathies

Start: 2004-10-31End: 2005-12-31Updated: 2014-09-22

SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

CompletedNCT00136019

UCB PharmaEpilepsy

Start: 2004-03-31End: 2006-08-31Target: 400Updated: 2014-09-22

A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

CompletedNCT00220415

UCB PharmaPartial Seizures With or Without Secondary Generalization

Start: 2004-05-31End: 2006-01-31Updated: 2014-09-22

A Trial to Assess the Efficacy and Safety of SPM 927 (Lacosamide) in Subjects With Painful Distal Diabetic Neuropathy

CompletedNCT00238524

UCB PharmaDiabetic Neuropathy

Start: 2003-12-31End: 2005-01-31Updated: 2014-09-22

Related Papers

Safety and tolerability of lacosamide monotherapy in the elderly: A subgroup analysis from lacosamide trials in diabetic neuropathic pain.

2017-09-115 citations

Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.

2015-09-2768 citations

Safety and tolerability of lacosamide monotherapy in elderly: A subgroup analysis from lacosamide trials in diabetic neuropathic pain (P1.239)

Neurology2015-04-06

Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.

2012-03-0166 citations